Grantopen🌐 United StatesPA-25-172
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
National Institutes of Health
Description
This Notice of Funding Opportunity (NOFO) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, healthcare delivery, and digital health and data science, and implementation science.
Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
CFDA: 93.399, 93.393
Details?
- Posted
- Nov 7, 2024
- Response deadline
- Jan 7, 2028, 5:00 AM UTC (478d)
- Type
- Grant
- Category
- 93.399, 93.393
- Status
- open
- Buyer
- National Institutes of Health
- Department
- HHS-NIH11
- Jurisdiction
- United States
- Reference #
- PA-25-172
- Has Description
- true
- Doc Type
- synopsis
- Opp Status
- posted
Contact
National Institutes of Health
grantsinfo@nih.govSimilar open opportunities
See opportunities like this one
GovBidAlerts matches this solicitation to similar open bids across 120,000+ open bids from 2,400+ sources. Create a free account to unlock them.
Create free accountno credit card required
This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.